

EN

Back



Pfizer Leads Price Hikes on 350 Drugs Despite US Pressure

Stock NewsThemesPfizer Leads Price Hikes on 350 Drugs Despite US Pressure

Pfizer Leads Price Hikes on 350 Drugs Despite US Pressure

Edgen Stock·Dec 31 2025, 13:34

Share to

Share to

Copy link

source:

[1] Defying Trump's Pressure, US to Raise Prices on 350 Prescription Drugs Next Year (https://wallstreetcn.com/articles/3762401 ...)

Related News

Corcept Therapeutics Plummets 48%, Marking Worst Day in 11 Years

Dec 31 2025, 14:45

Corcept Therapeutics Plummets 48%, Marking Worst Day in 11 Years

Corcept Therapeutics (CORP) stock plummeted 48% in its worst intraday performance in 11 years, signaling a potential fundamental crisis at the company.

NIO Plunges 5% as Chinese EV Stocks Lead Market Decline

Dec 31 2025, 14:44

NIO Plunges 5% as Chinese EV Stocks Lead Market Decline

The Nasdaq Golden Dragon China Index opened down 0.76%, dragged lower by a sharp sell-off in Chinese electric vehicle manufacturers, with NIO declining by 5%.

Shandong Zhanggu Faces CSRC Probe Over Financial Disclosures

Dec 31 2025, 14:34

Shandong Zhanggu Faces CSRC Probe Over Financial Disclosures

On December 31, Shandong Zhanggu Blower disclosed it is under investigation by the China Securities Regulatory Commission for suspected illegal financial reporting.